Importer of Controlled Substances Registration: Johnson Matthey, Inc., 22638 [2016-08847]

Download as PDF 22638 Federal Register / Vol. 81, No. 74 / Monday, April 18, 2016 / Notices The company plans to import small quantities of the listed controlled substances for the National Institute on Drug Abuse (NIDA) for research activities. The company plans to import analytical reference standards for distribution to its customers for research and analytical purposes. Placement of these drug codes onto the company’s registration does not translate into automatic approval of subsequent permit applications to import controlled substances. Approval of permit applications will occur only when the registrant’s business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of FDA approved or non-approved finished dosage forms for commercial sale. Dated: April 11, 2016. Louis J. Milione, Deputy Assistant Administrator. [FR Doc. 2016–08842 Filed 4–15–16; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Importer of Controlled Substances Registration: Johnson Matthey, Inc. ACTION: Notice of registration. Johnson Matthey, Inc. applied to be registered as an importer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Johnson Matthey, Inc. registration as an importer of those controlled substances. SUPPLEMENTARY INFORMATION: By notice dated December 21, 2015, and published in the Federal Register on December 29, 2015, 80 FR 81367, Johnson Matthey, Inc., Pharmaceutical Materials, 2003 Nolte Drive, West Deptford, New Jersey 08066–1742 applied to be registered as an importer of certain basic classes of controlled substances. Comments and request for hearings on applications to import narcotic raw material are not appropriate. 72 FR 3417, (January 25, 2007). Also no comments or objections were submitted for this notice. The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of Johnson Matthey, Inc. to import the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or mstockstill on DSK4VPTVN1PROD with NOTICES SUMMARY: VerDate Sep<11>2014 17:54 Apr 15, 2016 Jkt 238001 protocols in effect onMay 1, 1971. The DEA investigated the company’s maintenance of effective controls against diversion by inspecting and testing the company’s physical security systems, verifying the company’s compliance with state and local laws, and reviewing the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above-named company is granted registration as an importer of the following basic classes of controlled substances: Controlled substance Coca Leaves (9040) ..................... Thebaine (9333) ........................... Opium, raw (9600) ....................... Noroxymorphone (9668) .............. Poppy Straw Concentrate (9670) Fentanyl (9801) ............................ Schedule II II II II II II The company plans to import thebaine derivatives and fentanyl as reference standards. The company plans to import the remaining listed controlled substances as raw materials, to be used in the manufacture of bulk controlled substances, for distribution to its customers. Placement of these drug codes onto the company’s registration does not translate into automatic approval of subsequent permit applications to import controlled substances. Approval of permit applications will occur only when the registrant’s business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of FDA approved or nonapproved finished dosage forms for commercial sale. Dated: April 11, 2016. Louis J. Milione, Deputy Assistant Administrator. [FR Doc. 2016–08847 Filed 4–15–16; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Importer of Controlled Substances Registration: Meridian Medical Technologies ACTION: Notice of registration. Meridian Medical Technologies applied to be registered as an importer of a certain basic class of controlled substance. The Drug SUMMARY: PO 00000 Frm 00072 Fmt 4703 Sfmt 9990 Enforcement Administration (DEA) grants Meridian Medical Technologies registration as an importer of this controlled substance. By notice dated November 27, 2015, and published in the Federal Register on December 3, 2015, 80 FR 75691, Meridian Medical Technologies, 2555 Hermelin Drive, Saint Louis, Missouri 63144 applied to be registered as an importer of a certain basic class of controlled substance. No comments or objections were submitted for this notice. The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of Meridian Medical Technologies to import the basic class of controlled substance is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company’s maintenance of effective controls against diversion by inspecting and testing the company’s physical security systems, verifying the company’s compliance with state and local laws, and reviewing the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above-named company is granted registration as an importer of morphine (9300), a basic class of controlled substance listed in schedule II. The company manufactures a product containing morphine in the United States. The company exports this product to customers around the world. The company has been asked to ensure that its product, which is sold to European customers, meets the standards established by the European Pharmacopeia, administered by the Directorate for the Quality of Medicines (EDQM). In order to ensure that its product will meet European specifications, the company seeks to import morphine supplied by EDQM for use as reference standards. This is the sole purpose for which the company will be authorized by the DEA to import morphine. SUPPLEMENTARY INFORMATION: Dated: April 11, 2016. Louis J. Milione, Deputy Assistant Administrator. [FR Doc. 2016–08844 Filed 4–15–16; 8:45 am] BILLING CODE 4410–09–P E:\FR\FM\18APN1.SGM 18APN1

Agencies

[Federal Register Volume 81, Number 74 (Monday, April 18, 2016)]
[Notices]
[Page 22638]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-08847]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Registration: Johnson Matthey, 
Inc.

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Johnson Matthey, Inc. applied to be registered as an importer 
of certain basic classes of controlled substances. The Drug Enforcement 
Administration (DEA) grants Johnson Matthey, Inc. registration as an 
importer of those controlled substances.

SUPPLEMENTARY INFORMATION: By notice dated December 21, 2015, and 
published in the Federal Register on December 29, 2015, 80 FR 81367, 
Johnson Matthey, Inc., Pharmaceutical Materials, 2003 Nolte Drive, West 
Deptford, New Jersey 08066-1742 applied to be registered as an importer 
of certain basic classes of controlled substances. Comments and request 
for hearings on applications to import narcotic raw material are not 
appropriate. 72 FR 3417, (January 25, 2007). Also no comments or 
objections were submitted for this notice.
    The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 
958(a) and determined that the registration of Johnson Matthey, Inc. to 
import the basic classes of controlled substances is consistent with 
the public interest and with United States obligations under 
international treaties, conventions, or protocols in effect onMay 1, 
1971. The DEA investigated the company's maintenance of effective 
controls against diversion by inspecting and testing the company's 
physical security systems, verifying the company's compliance with 
state and local laws, and reviewing the company's background and 
history.
    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the above-named company is granted 
registration as an importer of the following basic classes of 
controlled substances:

------------------------------------------------------------------------
            Controlled substance                       Schedule
------------------------------------------------------------------------
Coca Leaves (9040).........................  II
Thebaine (9333)............................  II
Opium, raw (9600)..........................  II
Noroxymorphone (9668)......................  II
Poppy Straw Concentrate (9670).............  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The company plans to import thebaine derivatives and fentanyl as 
reference standards.
    The company plans to import the remaining listed controlled 
substances as raw materials, to be used in the manufacture of bulk 
controlled substances, for distribution to its customers. Placement of 
these drug codes onto the company's registration does not translate 
into automatic approval of subsequent permit applications to import 
controlled substances.
    Approval of permit applications will occur only when the 
registrant's business activity is consistent with what is authorized 
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import 
of FDA approved or non-approved finished dosage forms for commercial 
sale.

    Dated: April 11, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016-08847 Filed 4-15-16; 8:45 am]
 BILLING CODE 4410-09-P